Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011981

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 24,318 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Grant or award · Performance Share Unit +4,558 4,558 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Grant or award · Performance Share Unit +4,786 4,876 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Grant or award · Performance Share Option +7,368 7,368 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Grant or award · Performance Share Option +7,606 7,606 D
Loading xslF345X05/form4-05052025_080539.xml…